Huiping Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Prognostic Factors

Ejection Fraction

Circulating Tumor

Top Venues

Breast cancer research and treatment

Cancer medicine

British journal of cancer

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Yifei Chen, Ruyan Zhang, Ying Yan, Huiping Li, Guohong Song
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study. Breast cancer research and treatment (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Hanfang Jiang, Jianxin Zhong, Jing Wang, Guohong Song, Lijun Di, Bin Shao, Ruyan Zhang, Yaxin Liu, Anjie Zhu, Nan Wang, Huiping Li
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China. Cancer medicine 13 (10) (2024)
Hanfang Jiang, Jianxin Zhong, Jing Wang, Guohong Song, Lijun Di, Bin Shao, Ruyan Zhang, Yaxin Liu, Anjie Zhu, Nan Wang, Huiping Li
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China. Cancer medicine 13 (10) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Hanfang Jiang, Jianxin Zhong, Jing Wang, Guohong Song, Lijun Di, Bin Shao, Ruyan Zhang, Yaxin Liu, Anjie Zhu, Nan Wang, Huiping Li
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China. Cancer medicine 13 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer (2024)
Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping Li
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment 204 (3) (2024)
Yifei Chen, Ruyan Zhang, Ying Yan, Huiping Li, Guohong Song
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study. Breast cancer research and treatment 206 (3) (2024)
Yifei Chen, Ruyan Zhang, Ying Yan, Huiping Li, Guohong Song
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study. Breast cancer research and treatment 206 (3) (2024)
Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping Li
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment 204 (3) (2024)
Hanfang Jiang, Jianxin Zhong, Jing Wang, Guohong Song, Lijun Di, Bin Shao, Ruyan Zhang, Yaxin Liu, Anjie Zhu, Nan Wang, Huiping Li
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China. Cancer medicine 13 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping Li
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment (2024)
Yifei Chen, Ruyan Zhang, Ying Yan, Huiping Li, Guohong Song
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study. Breast cancer research and treatment 206 (3) (2024)
Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping Li
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment 204 (3) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Hanfang Jiang, Huiping Li, Guohong Song, Lijun Di, Bin Shao, Ying Yan, Xiaoran Liu, Yifei Chen, Ruyan Zhang, Ran Ran, Yaxin Liu, Xinyu Gui, Nan Wang, Huan Wang
Pegylated liposomal doxorubicin (Duomeisu ® ) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study. Breast cancer research and treatment (2023)
Hanfang Jiang, Huiping Li, Guohong Song, Lijun Di, Bin Shao, Ying Yan, Xiaoran Liu, Yifei Chen, Ruyan Zhang, Ran Ran, Yaxin Liu, Xinyu Gui, Nan Wang, Huan Wang
Pegylated liposomal doxorubicin (Duomeisu ® ) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study. Breast cancer research and treatment (2023)
Xin-Yu Gui, Xu Liang, Huiping Li
Effectiveness, safety, and impact on quality of life of eribulin-based therapy in heavily pretreated patients with metastatic breast cancer: A real-world analysis. Cancer medicine (2023)
Hao Liao, Jiayang Zhang, Tiantian Zheng, Xiaoran Liu, Jianxin Zhong, Bin Shao, Xiaoxi Dong, Xiaohong Wang, Pan Du, Bonnie L King, Shidong Jia, Jianjun Yu, Huiping Li
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 20 (1) (2022)
Han Bai, Jianjun Yu, Shidong Jia, Xiaoran Liu, Xu Liang, Huiping Li
Prognostic Value of the TP53 Mutation Location in Metastatic Breast Cancer as Detected by Next-Generation Sequencing. Cancer management and research 13 (2021)
Huiping Li, Guohong Song, Qiaoxia Zhou, Ran Ran, Hanfang Jiang, Ruyan Zhang, Yaxin Liu, Jiayang Zhang, Luping Meng, Liandong Ma, Ye Sun, Meiyu Wang, Qingqing Zhou, Honghua Yan, Qianxiang Zhou, Xunwei Dong, Youzhi Tong
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer. Breast cancer research and treatment 189 (3) (2021)
Xiaoran Liu, Andrew A Davis, Feng Xie, Xinyu Gui, Yifei Chen, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Ami N Shah, Amir Behdad, Firas Wehbe, Yong Huang, Jianjun Yu, Pan Du, Shidong Jia, Huiping Li, Massimo Cristofanilli
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China. Breast cancer research and treatment 190 (2) (2021)
Hanfang Jiang, Ruyan Zhang, Xiao-Ran Liu, Ran Ran, Jiayang Zhang, Yaxin Liu, Xinyu Gui, Yifei Chen, Kun Li, Bin Shao, Ying Yan, Xu Liang, Guohong Song, Lijun Di, Huiping Li
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016). Cancer medicine 10 (17) (2021)
Hanfang Jiang, Huiping Li
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis. BMC cancer 21 (1) (2021)
Ran Ran, Wenfa Huang, Yaxin Liu, Lin Shao, Xiaoran Liu, Yunyun Niu, Weiyao Kong, Shiping Bo, Hope S Rugo, Sijia Lu, Huiping Li
Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab. OncoTargets and therapy 13 (2020)
Hao Liao, Huiping Li
Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer. Cancer management and research 12 (2020)
Wenfa Huang, Ran Ran, Bin Shao, Huiping Li
Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis. Breast cancer research and treatment 178 (1) (2019)